Skip to main content

Table 2 Process and therapeutic indicators

From: Opposite trends in hospitalization and mortality after implementation of a chronic care model-based regional program for the management of patients with heart failure in primary care

  CCM group (n = 1761) Control group (n = 3522)
Creatinine and electrolyte tests
 Rate 2005-2009 55.8% 52.4%
 Rate 2010-2013 80.7% 65.3%
Beta-blocker therapy
 Rate 2005-2009 45.0% 43.0%
 Rate 2010-2013 65.1% 59.5%
ACE/ARBs therapy
 Rate 2005-2009 78.2% 76.7%
 Rate 2010-2013 81.0% 80.2%
  1. Rates of diagnostic and therapeutic indicators in the periods before and after chronic care model (CCM) project implementation among exposed and unexposed subjects. ARBs angiotensin receptor blockers, ACE angiotensin converting enzyme